Abstract
A multicenter, retrospective study of patients infected with carbapenem-resistant Pseudomonas aeruginosa who were treated with ceftolozane/tazobactam was performed. Among 35 patients, pneumonia was the most common indication and treatment was successful in 26 (74%). Treatment failure was observed in all cases where isolates demonstrated ceftolozane-tazobactam minimum inhibitory concentrations ≥8 μg/mL.
Original language | English (US) |
---|---|
Pages (from-to) | 158-161 |
Number of pages | 4 |
Journal | Clinical Infectious Diseases |
Volume | 65 |
Issue number | 1 |
DOIs | |
State | Published - Jul 1 2017 |
Keywords
- Ceftolozane
- P. aeruginosa
- carbapenem resistant
- multidrug resistant
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases